Average Co-Inventor Count = 16.10
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (5 from 1,141 patents)
2. Merck Patent Gmbh (3 from 2,918 patents)
3. The Institute of Cancer Research: Royal Cancer Hospital (1 from 49 patents)
6 patents:
1. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
2. 12084438 - GCN2 inhibitors and uses thereof
3. 12018029 - Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors
4. 11827627 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
5. 10988477 - GCN2 inhibitors and uses thereof
6. 10793563 - GCN2 inhibitors and uses thereof